What is Opus Genetics's acquisitions?

Opus Genetics (IRD) reported acquisitions of $0 in Q4 2025.

How has Opus Genetics's acquisitions changed year-over-year?

Opus Genetics's acquisitions decreased by 100.0% year-over-year, from $302.5K to $0.

What is the long-term trend for Opus Genetics's acquisitions?

Over 4 years (2021 to 2025), Opus Genetics's acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $100K to $0.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Opus Genetics IRD Acquisitions

Acquisitions at other companies

AbbVieABBV

$0-100%

Opko HealthOPK

$0-100%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness.

The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's acquisitions.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's acquisitions?: Opus Genetics (IRD) reported acquisitions of $0 in Q4 2025.
How has Opus Genetics's acquisitions changed year-over-year?: Opus Genetics's acquisitions decreased by 100.0% year-over-year, from $302.5K to $0.
What is the long-term trend for Opus Genetics's acquisitions?: Over 4 years (2021 to 2025), Opus Genetics's acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $100K to $0.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.